טוען...

Pre-implant phosphodiesterase-5 inhibitor use is associated with higher rates of severe early right heart failure after LVAD implantation: An INTERMACS analysis

BACKGROUND: Early right heart failure (RHF) occurs commonly in left ventricular assist device (LVAD) recipients, and increased right ventricular (RV) afterload may contribute. Selective pulmonary vasodilators, like phosphodiesterase-5 inhibitors (PDE5i), are used off-label to reduce RV afterload pri...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Circ Heart Fail
Main Authors:	Gulati, Gaurav, Grandin, E. Wilson, Kennedy, Kevin, Cabezas, Fausto, DeNofrio, David D, Kociol, Robb, Rame, J Eduardo, Pagani, Francis D, Kirklin, James K, Kormos, Robert L, Teuteberg, Jeffrey, Kiernan, Michael
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	2019
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6624075/ https://ncbi.nlm.nih.gov/pubmed/31181953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005537
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Pre-implant phosphodiesterase-5 inhibitor use is associated with higher rates of severe early right heart failure after LVAD implantation: An INTERMACS analysis

פריטים דומים